Inventor
YONG KONG
Inventor
CN
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07KPeptides40%
A61KPreparations for medical, dental or toiletry purposes20%
PatentTitleYear
12,552,870Anti-human interleukin 36 receptor monoclonal antibody and methods of use thereof to treat disease202612,378,309Anti-human thymic stromal lymphopoietin (TSLP) monoclonal antibody and use thereof to treat disease202512,351,626Anti-human interleukin-33 monoclonal antibody and use thereof202512,110,323Anti-human interleukin 17A monoclonal antibody and application thereof2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024Patents assigned to JIANGSU QYUNS THERAPEUTICS CO LTD (1)· patent assignee history
2024–2026Based in CN· patent location history
2025–2026Patents assigned to QYUNS THERAPEUTICS CO LTD (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| QYUNS THERAPEUTICS CO LTD | 3 | 2025–2026 |
| JIANGSU QYUNS THERAPEUTICS CO LTD | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 4 | 2024–2026 |